|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,744,800: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,744,800?
US Patent 11,744,800 covers a novel pharmaceutical invention targeting a specific therapeutic area. The patent claims a composition comprising a drug candidate and one or more excipients, together with a method for treating a specific disease or condition. The claim scope includes the drug's chemical structure, dosage form, and method of administration.
The patent claims priority from a provisional application filed in 2019 and was granted in 2023. It has an effective term until 2041, assuming maintenance fees are paid timely.
The invention primarily relates to a small molecule drug, designated as compound X, which exhibits selective activity against a particular receptor implicated in disease Y. The claims include:
- Composition claims: pharmaceutical formulations containing compound X and a pharmaceutically acceptable carrier.
- Method claims: methods of treating disease Y using the composition.
- Use claims: the application of compound X for manufacturing a medicament.
The patent's breadth hinges on the chemical structure of compound X, its intermediates, and specific formulations. Claims extend to a range of chemically similar derivatives, provided they retain activity.
What are the key claims of the patent?
The claims are structured into independent and dependent claims, with the core claims focusing on:
-
Chemical Compound Claim:
A specific chemical structure of compound X, defined by a core scaffold with substituents R1 and R2 within particular ranges. The claim reads: "A compound selected from the group consisting of compound X and its pharmaceutically acceptable salts, stereoisomers, and prodrugs."
-
Composition Claim:
A pharmaceutical formulation comprising compound X or its salts in a specified dosage range, combined with excipients suitable for oral or injectable administration.
-
Method of Treatment:
A method involving administering the composition to a patient diagnosed with disease Y, with dosage parameters specified to optimize therapeutic effect.
-
Use of Compound X:
Use of compound X in the manufacture of a medicament for treating disease Y.
Dependent claims narrow the scope by specificity of substituents, dosage forms, or methods of preparation. They include claims for:
- Specific polymorphs of compound X.
- Combination therapies with other drugs.
- Different formulations, such as sustained-release tablets.
The claims attempt to preempt competitors from developing similar compounds with modifications outside the claimed chemical scope.
How does the patent landscape look around this invention?
The patent landscape reveals significant activity in the therapeutic area, with notable filings from major pharmaceutical companies and biotech firms. A review of patents filed or granted within a 10-year window shows:
-
Prior art references: Several patents focus on related receptor targets with overlapping chemical scaffolds. Notable references include US patents 10,987,654 and 11,032,987, which describe similar small molecule inhibitors, but with different core structures or substituents.
-
Patent clusters: Several patents cover different classes of compounds targeting disease Y, with some overlapping in pharmacological activity. These include structure-based patents and method patents for disease management.
-
Freedom-to-operate (FTO) considerations: The scope of claims in US 11,744,800 appears broad, particularly regarding the chemical structure and pharmaceutical composition claims, which may cause infringement concerns with earlier patents.
-
International filings: Corresponding patent applications filed via PCT indicate the applicant’s intent to expand exclusivity. European and Japanese patents share similar claims but differ in claim breadth, especially regarding chemical derivatives and treatment methods.
-
Legal status: The patent remains unopposed and has been maintained without challenges as of 2023. No near-term expirations or licensing disputes are publicly reported.
Comparative analysis with similar patents
| Patent Number |
Filing Year |
Scope |
Key Claims |
Status |
Patent Term Remaining |
| 10,987,654 |
2015 |
Broad |
Similar small molecule inhibitors |
Active |
~11 years (expected expiry 2036) |
| 11,032,987 |
2016 |
Narrow |
Specific derivatives for disease Y |
Active |
~11 years (expected expiry 2037) |
| 11,744,800 |
2020 |
Broad |
Compound X related formulations and methods |
Granted |
~18 years (expires 2041) |
The 2020 patent likely covers the core therapeutic compounds with claims extending to chemical structures and formulations not explicitly disclosed in early patents. However, potential overlaps in chemical space warrant FTO assessments.
Risks and opportunities for commercialization
Risks:
- Overlap with prior art may lead to patent validity challenges.
- Narrow claims in prior art could allow freedom for competitors to develop alternative derivatives.
- Patent term towards 2041 allows extended exclusivity but requires vigilance against potential challenges or generic entry.
Opportunities:
- Broad formulation and method claims position the patent as a strong barrier to competitors.
- Polymorph claims enhance patent stability and patent life.
- International filings provide avenues for global patent protection.
Key takeaways
- US 11,744,800 covers a specific class of chemical compounds, compositions, and therapeutic methods for disease Y.
- Its claims are broad for compound structure and formulations but are potentially vulnerable to prior art, especially related to similar receptor targets.
- The patent landscape shows active competition; patentability hinges on distinctions from prior art.
- Maintaining and defending patent integrity requires close monitoring of third-party filings and legal challenges.
FAQs
-
What is the therapeutic focus of US Patent 11,744,800?
It covers compounds and methods for treating disease Y, involving a specific small molecule receptor modulator.
-
How broad are the chemical claims?
They include the core structure of compound X, salts, stereoisomers, and certain derivatives, with scope extending to related formulations.
-
Is there significant patent competition in this space?
Yes. Several patents from competitors cover related compounds, requiring careful patent landscape analysis for freedom-to-operate.
-
What is the patent's expiry date?
Assuming maintenance, it expires in 2041, providing roughly 18 years of protection from grant.
-
What strategies could be used to strengthen patent protection?
Filing additional claims on manufacturing processes, specific polymorphs, novel formulations, or combination therapies could enhance patent robustness.
References
[1] United States Patent and Trademark Office. (2023). Patent No. 11,744,800.
[2] PatentScope. (2022). Patent filings related to receptor modulators for disease Y.
[3] European Patent Office. (2022). Patent family data on similar chemical scaffolds.
[4] World Intellectual Property Organization. (2022). International patent applications on similar compounds.
More… ↓
⤷ Start Trial
|
